(Q50488873)

English

Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory.

scientific article published on 18 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory. (English)

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

1 reference

based on heuristic

inferred from title

extensively drug-resistant tuberculosis

1 reference

based on heuristic

inferred from title

Robin M. Warren

2

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

Nicolaas C Gey van Pittius

3

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

Elizabeth Streicher

6

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

Paul van Helden

4

object named as

Paul van Helden

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

author name string

Marinus Barnard

1

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

Marlein Bosman

5

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

Gerrit Coetzee

7

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

Richard O'Brien

8

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

language of work or name

0 references

publication date

18 October 2012

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

186

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

12

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

1298-1305

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

Drug-susceptibility testing in TB: current status and future prospects

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

GenoType MTBDRsl performance on clinical samples with diverse genetic background

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Subpopulation analysis of heteroresistance to fluoroquinolone in Mycobacterium tuberculosis isolates from Beijing, China

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Detecting drug-resistant tuberculosis: the importance of rapid testing.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201205-0960OC

21 January 2018

Identifiers

10.1164/RCCM.201205-0960OC

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23087027

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50488873&oldid=1774033689"